Acotiamide Has No Effects on Esophageal Motor Activity or Esophagogastric Junction Compliance

BACKGROUND/AIMS: The novel prokinetic drug acotiamide is used for treatment of functional dyspepsia. It is still unclear how acotiamide has effects on esophageal motor function. Esophageal peristalsis and esophagogastric junction (EGJ) compliance has an important role for prevention of esophageal mu...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Neurogastroenterol Motil
Asıl Yazarlar: Mikami, Hironobu, Ishimura, Norihisa, Okada, Mayumi, Izumi, Daisuke, Okimoto, Eiko, Ishihara, Shunji, Kinoshita, Yoshikazu
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Korean Society of Neurogastroenterology and Motility 2018
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5885723/
https://ncbi.nlm.nih.gov/pubmed/29605979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5056/jnm16111
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller